PD Dr. med. Markus Albertsmeier

PD Dr. med. Markus Albertsmeier is a highly specialized surgical oncologist and attending physician with a profound clinical focus on the operative treatment of complex malignancies. His primary area of clinical expertise lies in managing retroperitoneal and abdominal soft tissue tumors, where he frequently performs extensive, multivisceral resections necessary to achieve complete tumor clearance. Beyond his highly technical surgical work, he is deeply invested in understanding and mitigating the complications associated with these major procedures. His medical philosophy emphasizes balancing aggressive oncological efficacy with patient safety, carefully evaluating how intensive multimodal treatments—such as neoadjuvant radiotherapy, chemotherapy, and regional hyperthermia—impact postoperative surgical morbidity. In addition to his clinical responsibilities, he is a dedicated researcher and academic leader who actively drives forward the evidence base in surgical oncology. As the head of a major surgical clinical trials unit at a leading European university hospital, he bridges the critical gap between everyday patient care and advanced medical research, facilitating rigorous studies that help refine surgical standards globally. His academic work is widely published and heavily cited, contributing significantly to international consensus guidelines on sarcoma management. Recognizing the invaluable role of patient perspectives in shaping the future of medicine, he actively champions collaborative initiatives that unite clinical specialists and patients to prioritize research goals, ensuring that scientific advancements remain both clinically impactful and deeply patient-centered.